CAS 1282041-94-4

DSM265

CAS: 1282041-94-4

DSM265

Purity: ≥98%

Molecular weight: 415.33g/mol

Ref: 54-BUP16317

DSM265

CAS: 1282041-94-4

DSM265 (PfSPZ) is a dihydroorotic acid dehydrogenase inhibitor with antimalarial activity.DSM265 can be used for the treatment of malaria infections.

Formula: C₁₄H₁₂F₇N₅S

Purity: 99.79%

Color and Shape: Solid

Molecular weight: 415.33

Ref: TM-T15173

DSM265

CAS: 1282041-94-4

DSM265 is a novel triazolopyrimidine that inhibits the transcription and replication of RNA. It has shown to be effective against a variety of infectious diseases, such as hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus type 1 (HIV-1), and cytomegalovirus (CMV). DSM265 has also been found to have therapeutic potential in autoimmune diseases by inhibiting the activation of T cells. This drug was developed for patients with mitochondrial DNA polymerase deficiency, a rare genetic disorder that causes various symptoms, including deafness, liver disease, and neurological problems.

Formula: C₁₄H₁₂F₇N₅S

Purity: Min. 95%

Molecular weight: 415.33 g/mol

Ref: 3D-HBC04194